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During the past few years, extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and other 
species of Enterobacteriaceae have become a matter of great concern in human and veterinary 
medicine. Several studies in recent years documented the prevalence and occurrence of ESBL-
producing Enterobacteriaceae in food products such as meat, poultry and raw milk; therefore in this 
pilot study we examined imported raw frozen mackerel fish to determine the incidence of ESBL-
producing E. coli from Eastern Province of Saudi Arabia. From January to March, 2012, 45 samples were 
purchased from various supermarkets of this region and examined for the presence of ESBL-producing 
E. coli using ChromID ESBL agar plates and further confirmed by PCR amplification. Out of 45 mackerel 
fish samples, 23 (51.1%) were found to be positive for ESBL-producing E. coli and yielded 60 isolates. 
The higher rate of resistance was found to be with ampicillin (100%), piperacillin (96.7%), cefotaxime 
(93.3%), ceftriaxone (93.3%), tetracycline (53.3%), nalidixic acid (40%) and trimethoprim (30%). The least 
rate of resistance was recorded among chloramphenicol (15%), ciprofloxacin (15%), noroxin (11.7%) and 
nitrofurantoin (5%). All the 60 isolates in this study were found susceptible to amikacin, aztreonam, 
cefepime, ertapenem, gentamicin and kanamycin. Further characterization by PCR revealed that 49 
(82%) out of 60 isolates of ESBL-producing E. coli were confirmed to be blaCTX-M type and were negative 
for blaTEM and blaSHV genes. This is the first study to demonstrate the occurrence of ESBL-producing E. 
coli in imported raw frozen mackerel fish in Saudi Arabia and the study result indicates that the 
mackerel fish might be the possible reservoir of blaCTX-M gene and may contribute to the dissemination 
and transfer of these β-lactamase genes to humans through food chain. The high rate of occurrence of 
ESBL-producing E. coli in the mackerel fish indicates that there is an established reservoir of these 
bacteria in the mackerel fish. Further national wide studies are necessary to assess future trends in 
imported fish to Saudi Arabia. 
 






The increase and spread of extended spectrum beta-
lactamase (ESBL) producing Enterobacteriaceae over 
the past decade has become a global problem (Bradford, 





Bush, 2008; Ozcakar et al., 2011). The ESBLs are 
plasmid-encoded enzymes that inactivate a large number 
of β-lactam antibiotics such as extended-spectrum, 
broad-spectrum cephalosporins and monobactams. These 
β-lactamases are commonly inhibited by β-lactamase 
inhibitors, such as clavulanic acid, sulbactam, and 
tazobactam (Bush et al., 1995; Paterson and Bonomo, 
2005). In several studies, across the globe reported 
alarming high rate of ESBL producing Escherichia coli not 
only in human infections (Paterson and Bonomo, 2005; 
Perez et al., 2007; Cantón et al., 2008; Poeta et al., 
2008), but also in a wide range of food producing 
animals, (Ojer-Usoz et al., 2013), food products (Schmid 
et al., 2013) and environment (Mesa et al., 2006), 
showing that ESBL are not restricted to clinical settings 
alone.  The microbiological safety of fish and other fishery 
products is an important public health concern throughout 
the world (FAO, 2010). A recent study from China has 
identified fish as a reservoir of ESBL producing E. coli 
(Jiang et al., 2012). Since the ESBLs are located on 
plasmids, many of them are derived from mutations in 
blaSHV (Sulphydryl variable) and blaTEM (Temoneira) genes 
determined by amino acid substitutions around the active 
site. Apart from SHV and TEM types, E. coli isolates may 
additionally produce CTX-M (cefotaximase-Munchen) 
enzymes. CTX-M β-lactamases are more active against 
cefotaxime and ceftriaxone than against ceftazidime, 
even though point mutations can increase their activity 
against ceftazidime as well (Manoharan et al., 2011). The 
CTX-M enzymes are being discovered throughout the 
world and are becoming the most prevalent beta-
lactamases found in clinical isolates and now is considered 
the most prevalent ESBLs worldwide (Federico et al., 
2007; Livermore et al., 2007; Bonnet, 2004; Canton and 
Coque, 2006). The CTX-M enzymes have been reported 
to be detected from different food products and food 
producing animals that were recognized as reservoirs for 
ESBL-producing E. coli (Carattoli, 2008; Geser et al., 
2011; Egea et al., 2012). Recently, several studies have 
shown that these resistance genes entered and 
disseminated through the food chain via direct contact 
with humans and animals and could contribute to the 
spread of the these strains (Winokur et al., 2001; 
Oppegaard et al., 2001;  Mesa et al., 2006; Egea et al., 
2012).  
There is no data available about ESBL-producing 
bacteria in food and aquaculture products and food of 
animal’s origin in Saudi Arabia. Therefore, this study was 
conducted to estimate the incidence and to provide current 
baseline information on the antimicrobial resistance 
patterns and molecular characterization of ESBL-producing 




E. coli in imported mackerel fish purchased from several 




MATERIALS AND METHODS  
 
Sampling and isolation of ESBL producing E. coli 
 
A total of 45 imported mackerel fish samples with labeled information 
(the country of origin and the storage temperature) were purchased 
from different supermarkets in Eastern Province of Saudi Arabia. 
The purchased samples were collected and transported on ice bag 
to the Microbiology Research Laboratory, University of Dammam. 
Upon arrival, the samples were kept intact on ice and analyzed 
within 2 to 3 h of collection. The examination of the mackerel fish 
samples were carried out according to the Methods of Bacteriological 
Analytical Manual (BAM, 2011) and also other published protocol 
with modifications (Elhadi et al., 2004; Zhao et al., 2001). Briefly, 25 
g of samples (fish gills, intestines parts and skin) were placed into a 
stomacher bag containing 225 ml of EC broth (Oxoid, UK) and 
homogenized using a stomacher (Seward Stomacher 400 
Circulator, UK) for 2 min and incubated for 18 to 24 h at 35°C. After 
enrichment incubation, 0.1 ml was streaked on ESBL chromogenic 
agar and incubated overnight at 37°C, three to four pink to reddish 
colored colonies with distinct morphological were isolated and 
subjected to biochemical tests (indole positive and oxidase 




Antibiotic susceptibility testing 
 
Antimicrobial susceptibility was determined by the disk diffusion 
method on Muller-Hinton agar Plates (Oxoid, Baringstoke, 
Hampshire, United Kingdom) as recommended by the Clinical and 
Laboratory Standards Institute (CLSI, 2010). The isolates were 
tested against the following antibiotics (Baringstoke, Hampshire, 
United Kingdom) AK: Amikacin (30 µg); AP: Ampicillin (10 µg); 
AUG: augmentin (30 µg); ATM: aztreonam (30 µg); FEP: cefepime 
(30 µg); CTX: cefotaxime (30 µg); CAZ: ceftazidime (30 µg); CRO: 
ceftriaxone (30 µg); C: chloramphenicol (30 µg); CIP: ciprofloxacin 
(5 µg); ETP: ertapenem (10 µg); GM: gentamicin (10 µg); K: 
kanamycin (30 µg); NA: nalidixic acid (30 µg); NI: nitrofurantoin 
(300 µg); NOR: noroxin (10 µg);  PRL: piperacillin (100 µg); T: 
tetracycline (30 µg); TN: tobramycin (10 µg); TM: trimethoprim (5 
µg) and TS: Trimethoprim/sulfamethoxazole (25 µg). E. coli 
American Type Culture Collection (ATCC) 25922 was used as a 
reference strain for antimicrobial disk control. 
 
 
Phenotypic confirmation of ESBL by E-test  
 
E-test strips (Oxoid, UK) with concentration gradient of cefotaxime 
or ceftazidime at one end and cefotaxime or ceftazidime with 
Clavanic acid at the other end were accomplished according to the 
guidelines of the manufacturer for confirming ESBL production. 
ESBL production was determined by a ≥3 doubling dilutions 
decrease in the MIC of cefotaxime or ceftazidime in the presence of 
Clavanic acid. ESBL production was also recognized by the 
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Table 1. Nucleotide sequences of PCR primers. 
  
Gene  Primer sequence (5'-3') Amplicon size (bp) 
blaCTX-M 
F: CGCTGTTGTTAGGAAGTGTG 754 
R: GGCTGGGTGAAGTAAGTGAC  
   
blaTEM 
F: TTTCGTGTCGCCCTTATTCC 403 
R: CGTTGTCAGAAGTAAGTTGG  
   
blaSHV 
F: CGCCTGTGTATTATCTCCCT 293 




Table 2. Percentage of antibiotic agents tested against E. coli strains isolated from imported mackerel fish (n=60). 
 
Antimicrobial agents (µg) Resistant, n (%) Intermediate, n (%) Susceptible, n (%) 
Amikacin (30) 0 0 60 (100 ) 
Ampicillin (10) 60 (100) 0 0 
Augmentin (30) 1 (1.7) 0 59 (98.3) 
Aztreonam (30) 0 50 (83.3) 10 (16.7) 
Cefepime (30) 0 0 60 ( 100) 
Cefotaxime (30) 56 (93.3) 4 (6.7) 0 
Ceftazidime (30) 0 0 60 (100) 
Ceftriaxone (30) 56 (93.3) 4 (6.7) 0 
Chloramphenicol (30) 9 (15) 0 41 (68.3) 
Ciprofloxacin (5) 9 (15) 0 51 (85) 
Ertapenem (10) 0 0 60 (100) 
Gentamicin (10) 0 0 60 (100) 
Kanamycin (30) 0 0 60 100 ) 
Nalidixic acid (30) 24 (40) 0 36 (60) 
Nitrofurantoin (30) 3 (5) 0 57 (95) 
Noroxin (10) 7 (11.7) 0 53 (88.3) 
Piperacillin (10) 58 (96.7) 0 2 (3.3) 
Tetracycline (30) 56 (53.3) 0 4 (6.7 ) 
Tobramycin (10) 2 (3.3) 0 58 (96.7) 
Trimethoprim (5) 18 (30) 0 42 (70) 




appearance of a phantom zone in the cefotaxime or ceftazidime 
strip. A non-determinable (ND) result was declared when the MICs 




Genotypic characterization of β-lactamases  
 
All the isolates confirmed as ESBL producers were analyzed by 
using PCR amplification (Pitout et al., 1998; Poeta et al., 2008; 
Woodford et al., 2005). Genomic DNA was extracted by a standard 
heat lysis protocol and the same were used as the template. 
Amplification of TEM, SHV and CTX-M was performed with primer 
and cycling conditions presented in Table 1. 
 
 
RESULTS AND DISCUSSION  
 
Isolation of ESBL producing E. coli 
 
A total  of  60  isolates  of  ESBL-producing  E.  coli  were 
retrieved from 45 frozen imported mackerel fish samples 
that were obtained from supermarkets in Eastern Province 
of Saudi Arabia. In the present study, ChromID ESBL 
agar plates were used according to manufacturer’s 
guidelines. It was found to have excellent sensitivity and 
specificity in detecting ESBL producing E. coli resulting in 
reduction in time and amount of bench work.  
 
 
Antibiotic susceptibility testing 
 
Antibiotic susceptibility testing result are shown in Table 
2. Among all the total 60 study isolates, the higher 
percentage of resistance were found with piperacillin 
(96.7%), cefotaxime (93.3%) and ceftriaxone (93.3%) 
while, lowest resistance found with Tobramycin (3.3%) 
and Nitrofurantoin (5%). All the isolates were found to be




Table 3. Antibiotic resistant patterns and number of ESBL producing gene of E. coli strains 
isolated from imported mackerel fish (n=60). 
 








AP-PRL 1 1 0 0 
AP-NI-AUG 1 0 0 0 
AP-CRO-PRL 2 2 0 0 
AP-T-CRO-CTX-PRL 23 20 0 0 
AP-T-CRO-CTX-PRL-NA 15 13 0 0 
AP-T-CRO-CTX-PRL-TS-TM 9 5 0 0 
AP-T-C-NI-CTX-PRL-NA-TS-CIP-TN-TM 2 2 0 0 
AP-T-C-CRO-CTX-PRL-NA-TS-CIP-NOR-TM 7 6 0 0 




resistant to ampicillin whereas, all isolates were found to 
be susceptible to amikacin, cefepime, ceftazidime, 
ertapenem, gentamicin, and kanamycin. Unexpectedly, 
one isolate was found resistant against augmentin. 
83.3% isolates had intermediate susceptibility against 
Aztreonam raising serious concern. This decreasing 
Aztreonam susceptibility was in concordance to our 
recent unpublished study regarding antibiotic resistant E. 
coli in beef and shrimp isolated from the same region. 
Out of all the 60 strains of E. coli, 23 strains yielded the 
similar resistance pattern AP-T-CRO-CTX-PRL, 15 
strains yielded resistance pattern AP-T-CRO-CTX-PRL-
NA and 9 strains yielded resistance pattern AP-T-CRO-
CTX-PRL-TS-TM, respectively (Table 3). All the study 
isolates were found to be resistant to two or more 
antibiotics. The least discovered resistance patterns were 
AP-PRL and AP-NI-AUG, found in only one isolate each. 
A wide range of antibiotic classes are being used 
extensively in aquaculture, including aminopenicillins, 
amphenicols, macrolides, aminoglycosides, nitrofurans, 
fluoroquinolones, sulphonamides and tetracyclines (Heuer 
et al., 2009). The main consequence of this is the 
selection of MDR strains in the gut flora of fishes. During 
consumption of such contaminated fish products, the 
MDR strains are transferred to human gut and enter the 
food cycle (Heuer et al., 2009).   
A recent research data from Sweden has shown the 
acquisition of fecal carriage of CTX-M-type ESBL 
producing E. coli in travelers to different parts of the world 
from Sweden and with 32% acquisition rate after 
travelling to Asia (Tangden et al., 2010). Fecal carriage is 
believed to be the most important reservoir of ESBL-
producing bacteria in the community (Kluytmans et al., 
2013). Some published research data documented the 
contamination of food animals, retailed chicken meat and 
beef meat with the ESBL-producing Enterobacteriaceae 
(Smet et al., 2008; Machado et al., 2008; Doi et al., 2010; 
Overdevest et al., 2011; Kluytmans et al., 2013). 
Previous reports suggest that resistant E. coli strains are 
probably more likely to be transmitted from poultry to 
humans than are susceptible variants (Johnson et al., 
2007). A recent survey comparing resistance rates 
among E. coli from humans vs. from poultry, pigs, and 
cattle in 11 European countries found strong, statistically 
significant correlations for various groups of antibiotics 
(Vieira et al., 2011).  
Notably, for resistance to extended-spectrum 
cephalosporins, a significant correlation was found only 
between humans and poultry, implicating poultry as an 
important source for human-associated ESBL-producing 
E. coli. Infections with the antibiotic resistant bacteria and 
ESBL producing Enterobacteriaceae are associated with 
increased morbidity, mortality, and healthcare costs as a 
result of hospital acquired infections (Cosgrove, 2006; 
Tumbarello et al., 2010). ESBL-producing 
Enterobacteriaceae infections are increasingly frequent 
among community-dwelling patients without a history of 
hospitalization or antimicrobial use (Friedmann et al., 
2009; Valverde et al., 2004; Dubois et al., 2010). Based 
on this finding imported mackerel fish is an important 
reservoir for ESBL-producing E. coli. Consumption of this 
contaminated fish with ESBL producing E. coli may lead 
to the transmission of genetic elements containing 
resistance genes to the human intestinal micro-biota. The 
abundant use of antimicrobial agents in a production 
animal poses threat to human health. This has recently 
spurred the US Food and Drug Administration to propose 




Genotypic characterization of β-lactamases 
 
All the 60 ESBL producing E. coli isolates were subjected 
to PCR analysis and 49 (82%) were positive for CTX-M 
and negative for TEM and SHV genes as shown in Table 
3, Figures 1 and 2. The one isolate which was found 
resistant to Aztreonam was negative for CTX-M. The 
CTX-M production was highest among the E. coli 








Figure 1. Representative Agarose gel electrophoresis of DNA amplification of selected E. coli isolates obtained with the 
PCR method. Lane M: Bench Top 100 bp DNA ladder (Promega, USA); Lane CP: Positive control. Lane 27A, 27B, 
27C, 27D, 27E, 28A, 28B, 28C, 28E, 29D, 29E, 30A, 30C, CTX-M positive isolates. Lane 28D, 29A, 29B, 29C, and 












Figure 2.  Representative Agarose gel electrophoresis of DNA amplification of selected E. coli isolates obtained with the 
PCR method. Lane M: Bench Top 100 bp DNA ladder (Promega, USA); Lane CP, Positive control. Lane 34C, 36A, 36B, 






presenting the resistance pattern AP-T-CRO-CTX-PRL. 
TEM and SHV genes are often reported in ESBL-
producing Enterbacteriaceae isolated from Poultry meat 
(Machado et al., 2008; Kola et al., 2012). The ESBL 
producing E. coli with CTX-M type and negative blaSHV 
have been reported in wild birds in Germany (Guenther et 
al., 2010). Recent study from China demonstrated the 
presence of ESBL genes in farmed fish produced (Jiang 
et al., 2012). Infections due to ESBL-producing E. coli 
harboring ESBLs of the CTX-M classes have dramatically 
increased among human populations, particularly in the 
community setting (Livermore et al., 2007). There is very 
limited data available on the occurrence or prevalence of 
ESBL-producing Enterobacteriaceae in marine fish and in 
imported fish to Saudi Arabia. There is only one study to 
best of our knowledge, reported from China by Jiang et 
al. (2012) that described the prevalence of β- lactamase 
in E. coli isolated from farmed fish (Jiang et al., 2012). 
There is no data available on “pubmed" search 
(http://www.ncbi.nlm.nih.gov/) for Saudi Arabia and other 
Middle Eastern countries. As seen in our study, a 
predominance of CTX-M gene in E. coli isolated from 
food producing animals was reported in some European 
countries (Aarestrup et al., 2006; Girlich et al., 2007; 





The result of this study raises serious food safety concerns 
regarding the high prevalence of ESBL producing E. coli 
in the mackerel fish. This is the first study to report the 
high prevalence of ESBL-producing E. coli in the 
imported mackerel fish in Eastern Province of Saudi 
Arabia. The extensive prevalence of extended spectrum 
β-lactamase producing genes and high levels of co-
resistance in E. coli detected in this study are of great 
concern and efforts should be made to monitor antibiotic 
resistance in aquaculture products, as this represents a 
major reservoir of antibiotic resistance.  Larger studies 
should be undertaken in different geographical regions of 
the country to address these issues. 
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